Recent studies indicate that popular weight-loss medications such as Ozempic and Wegovy might offer benefits for treating or preventing certain cancers. These findings highlight new advantages of GLP-1s, which are used by one in eight American adults.
William Brangham provides insights into this medical development. He is a recognized correspondent, producer, and substitute anchor for PBS News Hour. Additionally, he hosts Horizons on PBS.